The alternative cap-binding complex is required for antiviral defense in vivo
March 10, 2020 10:07 amGebhardt, A., V. Bergant, D. Schnepf, M. Moser, A. Meiler, D. Togbe, C. Mackowiak, L. S. Reinert, S. R. Paludan, B. Ryffel, A. Stukalov, P. Staeheli, and A. Pichlmair. 2019. The alternative cap-binding complex is required for antiviral defense in vivo. PLoS Pathog 15: e1008155.
Categorised in:
This post was written by Heike Ufheil